Sponsored by Philips

HRS 2011: Which patients gain the most benefit from ablation therapy for AF?

Published 06 May 2011 | Article by Excerpta Medica


GetInsideHealth

HRS 2011: Which patients gain the most benefit from ablation therapy for AF?

Analysis of data from a large German registry shows that patients with hypertensive heart disease (HHD) tend to have more benefit from ablation therapy for atrial fibrillation (AF) than those with hypertrophic cardiomyopathy (HCM).


To read the full article, please register for GetInsideHealth below.

Register for GetInsideHealth

GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.

Please fill in the form below to register.

Already Registered?

Please login using
form at top of page


Fields with an asterisk (*) are mandatory



About you




 

Login information


   


 


 

 

Newsletter

To personalise your experience, please specify which specialty areas you are interested in

Additional information



 


 



Featuring content from:
Excerpta Mediaca GNM healthcare
All files and contents featured or mentioned are the property of their respective owners and subject to copyright and intellectual property rights.
GetInsideHealth

Thank you for registering

To edit your details at any time, and to receive our exclusive email newsletter and regular updates in the world of health and well-being, please go to the My Account area.

Close popup

Thank you

your topic suggestion has been received by the GetInsideHealth editorial board. We appreciate your contribution in making GetInsideHealth's content more relevant and user-focused